1.Advances in methods and techniques for the study of polysaccharide in vivo processes and immunomodulatory mechanisms
Chi-yun ZHU ; Ping XIAO ; Yue-yue FANG ; Meng-ting LAI ; Jin-ao DUAN
Acta Pharmaceutica Sinica 2024;59(2):322-335
In recent years, polysaccharides have received much attention because of their high safety and good immunological activity. The study of polysaccharide
2.Regulatory effect of Flos Abelmoschus manihot in mice with inflammatory bowel disease based on gut microbiota sequencing and untargeted lipidomics
Shu-hui YANG ; Cheng-xi LI ; Jian-ping LI ; Yu-meng WANG ; Yun LIU ; Jin-ao DUAN ; Jian-ming GUO
Acta Pharmaceutica Sinica 2022;57(12):3546-3556
In this study, the ameliorative effects of
3.Chemical constituents of Glechoma longituba.
Nian-Yun YANG ; Jin-Ao DUAN ; Ping LI ; Shi-Hui QIAN
Acta Pharmaceutica Sinica 2006;41(5):431-434
AIMTo study the chemical constituents of Glechoma longituba (Nakai) Kupr.
METHODSManifold chromatography methods were used to separated the chemical constituents, and the chemical structures were determined by spectral analyses.
RESULTSNine compounds were isolated from Glechoma longituba and identified, as: glecholone (1), 6R,9R-3-oxo-alpha-ionol (2), S(+)-dehydrovomifoliol (3), vomifoliol (4), corosolic acid (5), quercetin (6), stigmastenol (7), myristic acid (8) and triacontanol (9).
CONCLUSIONCompound 1 is a new compound. Compounds 2 - 9 were isolated from this plant for the first time.
Cyclohexanones ; chemistry ; isolation & purification ; Lamiaceae ; chemistry ; Molecular Conformation ; Molecular Structure ; Plant Components, Aerial ; chemistry ; Plants, Medicinal ; chemistry ; Triterpenes ; chemistry ; isolation & purification
4.Simultaneous determination of clevidipine butyrate and its metabolite clevidipine acid in dog blood by liquid chromatography-tandem mass spectrometry.
Hui-hui WEI ; Yuan GU ; Yan-ping LIU ; Guang-li WEI ; Yong CHEN ; Chang-xiao LIU ; Duan-yun SI
Acta Pharmaceutica Sinica 2015;50(10):1290-1296
A rapid, sensitive and simple liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was developed and validated for the simultaneous determination of clevidipine butyrate and its primary metabolite clevidipine acid in dog blood. After one-step protein precipitation with methanol, the chromatographic separation was carried out on an Ecosil C18 column (150 mm x 4.6 mm, 5 µm) with a gradient mobile phase consisting of methanol and 5 mmol · L(-1) ammonium formate. A chromatographic total run time of 13.0 min was achieved. The quantitation analysis was performed using multiple reaction monitoring (MRM) at the specific ion transitions of m/z 454.1 [M-H]- --> m/z 234.1 for clevidipine butyrate, m/z 354.0 [M-H]- --> m/z 208.0 for clevidipine acid and m/z 256.1 [M-H]- --> m/z 227.1 for elofesalamide (internal standard, IS) in the negative ion mode with electrospray ionization (ESI) source. The linear calibration curves for clevidipine butyrate and clevidipine acid were obtained in the concentration ranges of 0.5-100 ng · mL and 1-200 ng · mL(-1), separately. The lower limit of quantification of clevidipine butyrate and clevidipine acid were 0.5 ng · mL(-1) and 1 ng · mL(-1). The intra and inter-assay precisions were all below 12.9%, the accuracies were all in standard ranges. Stability testing indicated that clevidipine butyrate and clevidipine acid in dog blood with the addition of denaturant methanol was stable under various processing and/or handling conditions. The validated method has been successfully applied to a pharmacokinetic study of clevidipine butyrate injection to 8 healthy Beagle dogs following intravenous infusion at a flow rate of 5 mg · h(-1) for 0.5 h.
Animals
;
Butyrates
;
blood
;
pharmacokinetics
;
Calibration
;
Chromatography, Liquid
;
Dogs
;
Infusions, Intravenous
;
Pyridines
;
blood
;
pharmacokinetics
;
Tandem Mass Spectrometry
5.Research on Chinese medicine pairs (I)--Their formation and development.
Yu-Ping TANG ; Xiao-Yun SHU ; Wei-Xia LI ; Min ZHU ; Shu-Lan SU ; Da-Wei QIAN ; Xin-Sheng FAN ; Jin-Ao DUAN
China Journal of Chinese Materia Medica 2013;38(24):4185-4190
Chinese medicine pair (CMP) was frequently applied in traditional Chinese medicine (TCM) clinic, and its significance was shown in long-term clinical practices and many accumulated experiences. It is the unique combination of two relatively fixed Chinese medicines in TCM clinic with the basic feature and principle of TCM compatibility, is the most fundamental and the simplest form of TCM formulae with certain theory basis and combinatory reason, which is proven effective. And the unique combination is frequently used for achieving mutual reinforcement or detoxication. CMP is an intermediate point between single herb and many TCM formulae, reflecting the regularity of TCM formulae compatibility and connotation of differential treatment. This paper analyzed and summarized the basic characteristics, development process and research significance of CMP, which aims to lead the modern basic and applied research on compatibility theory of CMP.
Drug Interactions
;
History, 16th Century
;
History, 17th Century
;
History, 18th Century
;
History, 19th Century
;
History, 20th Century
;
History, 21st Century
;
History, Ancient
;
Medicine, Chinese Traditional
;
history
;
methods
6.mf-ERG effective evaluation of early and background diabetic retinopathy
Cun-Wen, PEI ; Li, WEN ; Xue-Mei, FENG ; Shao-Yang, SHI ; Li, FA ; Hong-Yu, WANG ; Yan-Ping, SUN ; Yun-Dong, DUAN ; Hong-Tao, YANG
International Eye Science 2014;(12):2217-2219
AlM: To measure the retinal electrical activities in patients with diabetic retinopathy ( DR ) by applying multifocal electroretinogram ( mf-ERG) and evaluate the degree of visual damage at different stages of DR
METHODS:Thirty cases ( 30 eyes ) aged 50 ~70 years old, excluding other diseases, were as normal group, and 99 cases ( 99 eyes ) diagnosed with type 2 diabetes were as experiment group. The cases received mf-ERG examination in the standard state, respectively. The results were statistically analyzed
RESULTS: For DR patients with early and background stage, the reaction density of mf - ERG P1 wave decreased as the disease worsened, significantly reduced in non - proliferating stage and decreased more significantly in the background of the stage Ⅲ. This showed that in the macula, electrical activity had weakened before the retina without visual or morphological changes, and with the development of the disease, the electrical activity decreased more obviously.
CONCLUSlON:mf-ERG can evaluate the severity of DR, especially suit in the early and background period of DR.
7.Microvascular decompression for trigeminal neuralgia in elderly patients
Sheng-Wei QIAN ; Yun-Ping DUAN ; Ji-Zhi ZHANG ; Dian-Shi JIN
Chinese Journal of Neuromedicine 2009;8(4):399-401,404
Objective To assess the efficacy and safety of microvascular decompression for treatment of trigeminal neuralgia in elderly patients. Methods The clinical data of29 elderly patients (above 65 years old) with trigeminal neuralgia treated with microvascular decompression were retrospectively reviewed to analyze the outcomes of the surgery and complications in comparison with those of younger patients below 65 years of age. Results Good therapeutic effects were achieved in both groups without obvious difference between them,the rate ofpostoperative pain relieffor the elderly group is 93.10%,96.36%for the control group.The elderly patients showed some special anatomical and systemic features in relation to aging,including the presence of brain atrophy,obvious arteriosclerosis in the culprit arteries(the elderlygroupis about 1/4,the control group is about 1/10),multiple systemic diseases(the elderly group accounted for 71.69%,41.81%for control group),and increased risk of surgical complications(one of the elderly group appears brainstem infarction,2 cases of lower extremity deep VenOUS thromboembolism disease). Conclusion Microvascular decompression provides an effective cure or pain relief for most elderly patients with trigeminal neuralgia with the application of effective perioperative treatment.
8.Clinical application of medial neurocutaneous flap with perforator vessel in upper arm.
Jian LIN ; Yun-Lan YU ; Zhen-Duan YING ; Sheng-Jun ZHU ; He-Ping ZHENG
Chinese Journal of Plastic Surgery 2009;25(5):355-357
OBJECTIVETo report the application of medial neurocutaneous flap with perforator vessel in upper arm.
METHODSBased on the perforator vessel of medial deep main blood vessel in upper arm and blood supply of neurocutaneous flap, as well as their interrelation with vascularity of fascia skin, we designed the medial neurocutaneous flap with perforator vessel in upper arm to repair skin defects in shoulder, arm and elbow joint in 5 cases.
RESULTSAll the flaps survived completely with primary healing. The patients were followed up for 6-12 months. The contour of flaps and the function of shoulder and elbow joint were satisfactory.
CONCLUSIONThe neurocutaneous flap has a reliable blood supply and easily performed. It is very desirable for repairing skin defect in upper extremity.
Adult ; Arm ; surgery ; Brachial Plexus ; surgery ; Female ; Humans ; Male ; Middle Aged ; Skin Transplantation ; Surgical Flaps ; blood supply ; innervation ; Wounds and Injuries ; surgery ; Young Adult
9.Investigation of Mycoplasma Pneumoniae Antibodies in Children in Shanghai Meilong Area
jian-ping, CHEN ; heng-tao, LI ; bo, YANG ; jian-yuan, ZHOU ; kun, GAO ; yun-gang, DUAN ; li-jue, SHEN ; su-hua, LI
Journal of Applied Clinical Pediatrics 2003;0(10):-
Objective To understand the mycoplasma pneumoniae(MP) infection degree in community children by testing specific IgM antibodies against MP in different age bracket group in Shanghai Meilong area. Methods Using random sampling method, blood specimens of 1 817 children from kindergartens and primary or junior high schools in Meilong area were obtained. Children were from 2 to 15 years old, 969 males, 848 females. The specimens were tested for IgM antibodies against MP using with gelatin particle agglutination test. The data were statistically analyzed using with ?2 test. Results Five hundred and fifty-nine (30.7%) IgM antibodies against MP were positive from 1 817 blood specimens. The positive percentages were 27.34% and 34.66% for males and females, which had significant difference(?2=11.383 P=0.001). The higher percentage was detected from kindergarten children than primary and junior high school children(P=0). The positive percentages of anti-mycoplasma IgM had no significant differences between different kindergartens and primary schools(P=0.526,0.232). On the contrary, between different junior high schools, there were siginificant differences (?2=9.825 P=0.002). Conclusions MP is an important pathogenic mycoplasma cause for respiratory tract infections in Meilong area. It is relative to childhood asthma. The prevention and cure of MP infection for children shall be paid more attention.
10.Anti-SARS virus activities of different recombinant human interferons in cell culture system.
Zhao-jun DUAN ; Li-lan ZHANG ; Zhi-ping XIE ; Zhi-ai YU ; Li-ping ZHANG ; Bin ZHANG ; Yong-qing LIU ; Jian-wei WANG ; Wu-ping LI ; Cheng-hai ZHANG ; Xue-jun MA ; Yue-long SHU ; Shu-min DUAN ; De-xin LI ; Yun-de HOU
Chinese Journal of Experimental and Clinical Virology 2003;17(3):205-208
BACKGROUNDTo study the anti-SARS virus activities of different recombinant human interferons on the cell culture system.
METHODSAnti-SARS virus activities of interferons were determined by using CPE inhibition test in human skeletal muscle sarcoma (Rda) cell culture.
RESULTSThe average minimum amount of interferon alpha 2b, alpha 1b, beta 1b or omega 1b to inhibit 50% CPE in Rda cell culture was (160.5+/-129.5) IU/ml, (149.0+/-71.7) IU/ml, (69.5+/-61.5) IU/ml, (87.3+/-47.1) IU/ml, respectively or (0.6+/-0.5) ng/ml, (10.6+/-5.1) ng/ml, (3.5+/-3.1) ng/ml, (0.9+/-0.5) ng/ml, respectively.
CONCLUSIONAll the tested recombinant interferons showed anti-SARS virus activities on the Rda cell culture with different sensitivities.
Antiviral Agents ; pharmacology ; Cell Line, Tumor ; Humans ; Interferon Type I ; pharmacology ; Interferon-alpha ; pharmacology ; Recombinant Proteins ; SARS Virus ; drug effects ; Severe Acute Respiratory Syndrome ; drug therapy ; virology